Clinical Trials Browser

Phase 2 × Glutamate Carboxypeptidase II × 30 days × Clear all

NCT04895735 2026-06-04

MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer

Phase 2 Active not recruiting

45 enrolled 12 charts

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

NCT06632977 2026-06-02

PREDICT

Phase 2 Recruiting

Prostatic Neoplasms